latest news releases from the newsroom
Peoples Bancorp Changes Transfer Agent
AUBURN, Ind., May 12, 2009 (GLOBE NEWSWIRE) -- The Board of Directors of Peoples Bancorp (Pink Sheets:PBNI) announced that Registrar and Transfer Company has been appointed as its Transfer Agent and Registrar. Registrar & Transfer has been in business since 1899 and specializes in companies such as ours. Chairman of the Board, G. Richard Gatton said, "Registrar and Transfer will provide our shareholders excellent customer service and will be more responsive to our shareholder's needs."
Momenta Pharmaceuticals to Present At the Deutsche Bank 34th Annual Health Care Conference
CAMBRIDGE, Mass., May 12, 2009 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard Shea, Chief Financial Officer, will deliver a corporate presentation at the Deutsche Bank 34th Annual Health Care Conference on Tuesday, May 19th at 3:55 pm EDT. The conference will be held at the InterContinental Hotel in Boston.
WSB Financial Group
WSB Financial Group, Inc. Stock to be Delisted From NASDAQ
SEATTLE, May 12, 2009 (GLOBE NEWSWIRE) -- WSB Financial Group, Inc. (Nasdaq:WSFG), announced today that as a result of the recent, previously announced closure of the Company's wholly-owned subsidiary and principal asset, Westsound Bank, and the insolvency and expected liquidation of the Company, trading in the Company's common stock was halted by The Nasdaq Stock Market starting on Monday, May 11, 2009, and the Company was notified by NASDAQ on May 12, 2009, that the Company's stock will be delisted from NASDAQ on May 21, 2009. This action is being taken by NASDAQ pursuant to its Listing Rules 5100, 5110(b) and IT-5100-1.
Competitive Technologies, Inc.
Competitive Technologies Announces New Patent for Nanoparticle Bone Biomaterial
FAIRFIELD, Conn., May 12, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that its bone nanoparticle biomaterial technology has been issued a third patent supporting the first two patents and providing additional claims regarding the preparation of the primary components of the bone cement. CTT has an exclusive agreement with the University of South Carolina Research Foundation (USCRF) to license and commercialize the injectable, flowable, fast-curing, calcium phosphate-based nanotechnology biomaterial developed by Dr. Brian R. Genge, a research professor in the Department of Chemistry and Biochemistry at USC.